Bone Biologics Corp — Director's Dealing 2024

Sep 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2024-09-17

Reporting Person: Angle Siddhesh Rajendra (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-17	Non-Employee Stock Option	$1.73	A	30713	Acquired	2034-09-17	Common Stock (30713)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Employee Stock Option	$5.12	2033-09-13	Common Stock (10721)	10721	Direct
Non-Employee Stock Option	$387.26	2027-08-23	Common Stock (154)	154	Direct
Non-Employee Stock Option	$844.80	2032-01-01	Common Stock (37)	37	Direct
Non-Employee Stock Option	$1260.00	2031-10-26	Common Stock (13)	13	Direct
Non-Employee Stock Option	$1260.00	2031-10-15	Common Stock (84)	84	Direct

Footnotes

F1: This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company.

F2: This option is fully exercisable as of the date of this report.